Phoenix, AZ (PRWEB) July 17, 2014 -- Arizona Pet Vet Family of Animal Hospitals is hosting San Diego, California based Regenerative Veterinary Medicine company, Vet-Stem, Inc., for a summer session of RACE approved Credentialing Courses and wet-labs on stem cell therapy. AZ Pet Vet’s Family of 17 Animal Hospitals has been offering Vet-Stem’s Regenerative Cell Therapy to its small animal patients since 2010, and continuously strives to educate their team members on cutting-edge services like stem cell therapy.
Since Vet-Stem’s last training session with AZ Pet Vet in the summer of 2013 the number of pets diagnosed with arthritis has increased as much as an estimated 13% say industry sources. As many as 65% of dogs between the ages of 7 and 11 years old will be inflicted with some degree of arthritis. For certain specific breeds the percentage is as high as 70%, with an additional estimated 7% remaining undiagnosed. AZ Pet Vet’s Family of Animal Hospitals equips their veterinarians with a complete package of services to help diagnose and treat dogs that are suffering pain or inflammation from osteoarthritis or polyarthritis. Stem cell therapy is one of these services, most commonly used to help decrease inflammation, help with the pain of osteo or polyarthritis, as well as other joint or ligament issues, and muscle injuries.
Vet-Stem’s Corey Orava, DVM will be leading a series of daily training sessions which include a RACE (Registry of Approved Continuing Education from the American Association of Veterinary State Boards) approved credentialing course, and the ability to consult on potential stem cell therapy cases with current patients of AZ Pet Vet’s Family of Animal Hospitals. Each of these sessions will help veterinarians and their staff to learn the ins and outs of stem cell therapy, as well as benefit from a hands-on experience to bring the best care to their patients and pet owners. Under the mentorship of Dr. Orava all of the 17 AZ Pet Vet Animal Hospitals will have the potential to collect fat and inject stem cells on qualifying pet patients.
AZ Pet Vet is a family of 17 animal hospitals with one vision: to provide the best comprehensive care for their highly valued patients. Whether it be routine wellness, or other type of medical care, AZ Pet Vet provides loving care and treatment for pets. As animal lovers and pet owners, they understand the connection owners have with your pet. The doctors and staff at each hospital strive to build a long term relationship with their client families and their pets, always making recommendations in the pet’s best health interest. The AZ Pet Vet Family of Animal Hospitals offer complete veterinary care from wellness, to vaccines, spays and neuters, dental, surgical and now regenerative medicine. Their animal hospital locations can be easily found at http://www.arizonapetvet.com/.
Since its formation in 2002, Vet-Stem, Inc. has endeavored to improve the lives of animals through regenerative medicine. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem pioneered the use of regenerative stem cells for horses, dogs, cats, and some exotics. In 2004 the first horse was treated with Vet-Stem Regenerative Cell Therapy for a tendon injury that would normally have been career ending. Ten years later Vet-Stem celebrated its 10,000th animal treated, and the success of establishing stem cell therapy as a proven regenerative medicine for certain inflammatory, degenerative, and arthritic diseases. As animal advocates, veterinarians, veterinary technicians, and cell biologists, the team at Vet-Stem tasks themselves with the responsibility of discovering, refining, and bringing to market innovative medical therapies that utilize the body’s own healing and regenerative cells. For more information about Vet-Stem and Regenerative Veterinary Medicine, visit http://www.vet-stem.com or call 858-748-2004.
Aurora D Rosas, Vet-Stem, Inc., http://www.vet-stem.com/, +1 858-748-2004 Ext: 207, [email protected]
SOURCE Vet-Stem, Inc.